Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute

Clin Infect Dis. 2024 May 6:ciae246. doi: 10.1093/cid/ciae246. Online ahead of print.
No abstract available

Keywords: CLSI; amoxicillin clavulanate; antimicrobial susceptibility testing; pharmacodynamics; pharmacokinetics; susceptibility.